Compound Detail
CHEMBL274654
ORANTINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL274654 |
| Name | ORANTINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | NHFDRBXTEDBWCZ-ZROIWOOFSA-N |
36
Targets
62
Activities
2
Assay Types
0
PK Parameters
20
Publications
6
Known Names
10
Indications
3
Mechanisms
Molecular Properties
310.4
MW (Da)
3.14
ALogP
2
HBA
3
HBD
82.2
PSA (Ų)
0.76
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Fibroblast growth factor receptor inhibitor | INHIBITOR | Fibroblast growth factor receptor | ✓ | ✓ |
| Platelet-derived growth factor receptor inhibitor | INHIBITOR | Platelet-derived growth factor receptor | ✓ | ✓ |
| Vascular endothelial growth factor receptor 2 inhibitor | INHIBITOR | Vascular endothelial growth factor receptor 2 | ✓ | ✓ |
Indications
Carcinoma, Hepatocellular Breast Neoplasms Colorectal Neoplasms Kidney Neoplasms Lung Neoplasms Multiple Myeloma Neoplasms Pancreatic Neoplasms Prostatic Neoplasms, Castration-Resistant Stomach Neoplasms
Activity Summary
IC50 31 meas. best 7.55
Kd 31 meas. best 9.52
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29935772 | 10.1016/j.bmcl.2018.06.026 | No relevant target | 10 |
| 12646019 | 10.1021/jm0204183 | Platelet-derived growth factor receptor | 7 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 20403700 | 10.1016/j.bmc.2010.03.052 | B16-F10 | 3 |
| 22370340 | 10.1016/j.bmc.2012.01.029 | COLO 205 | 3 |
| 22739090 | 10.1016/j.bmc.2012.05.068 | B16-F10 | 3 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 17850214 | 10.1042/bj20070797 | Unchecked | 2 |
| 17850214 | 10.1042/bj20070797 | Aurora kinase C | 2 |
| 19110422 | 10.1016/j.bmcl.2008.12.023 | HUVEC | 2 |
| 17618113 | 10.1016/j.bmcl.2007.06.058 | Fibroblast growth factor receptor 1 | 2 |
| 12646019 | 10.1021/jm0204183 | No relevant target | 2 |
| 10602697 | 10.1021/jm9904295 | Vascular endothelial growth factor receptor 2 | 2 |
| 29935772 | 10.1016/j.bmcl.2018.06.026 | Receptor-type tyrosine-protein kinase FLT3 | 2 |
| 10602697 | 10.1021/jm9904295 | Epidermal growth factor receptor | 2 |
| 10602697 | 10.1021/jm9904295 | Platelet-derived growth factor receptor beta | 2 |
| 10602697 | 10.1021/jm9904295 | Fibroblast growth factor receptor 1 | 2 |
Data from ChEMBL 36 via Core Engine